FATE FY 2020 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FATEFate Therapeutics, Inc.

$142M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31M+194.3% YoY

Gross Profit

-$94M-299.6% margin

Operating Income

-$128M-407.5% margin

Net Income

-$173M-551.6% margin

EPS (Diluted)

$-2.10

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$44M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$622M

Total Liabilities

$238M

Stockholders' Equity

$384M

Cash & Equivalents

$167M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$11M	+194.3%
Gross Profit	-$94M	$11M	-981.9%
Operating Income	-$128M	-$101M	-27.2%
Net Income	-$173M	-$98M	-76.7%